NOHO (OTC:NOHO) is a reminder of how tangled the identity of a deep-penny OTC ticker can become. The symbol has long been associated with Novation Holdings Inc, but market-data providers now list the entity under a different corporate name, reflecting the kind of rebranding …
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) occupies a corner of biotech where scientific promise collides with penny-stock economics. The Israel-based clinical-stage company is developing a combination therapy for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease with few effective treatments, yet its Nasdaq-listed shares trade well …
A commercial launch, a product recall and a pending FDA decision are colliding at once for InspireMD, Inc (NASDAQ: NSPR), and the stock's latest dip reflects a company in the middle of a delicate transition. The Israel-based, Nasdaq-listed developer of embolic-protection stents is trying …
A rebrand, a new chief executive and a coveted FDA designation have combined to give NovaBridge Biosciences (NASDAQ:NBP) one of the more eventful years in immuno-oncology's small-cap ranks. The company that most investors knew until recently as I-Mab has reset its identity around a …
● The larger overhang is the proposed Scancell combination and the outcome of the company's strategic review.
A relatively new ticker on the Nasdaq, Niki BioSolutions, Inc (NASDAQ:NIKI) is drawing attention as a freshly rebranded clinical-stage biopharmaceutical company still establishing its market identity. The shares eased in early-September 2026 trading, a modest single-session slip that fits the pattern of a small, …
● Neumora Therapeutics develops therapies for central-nervous-system and neuropsychiatric conditions, an area of large unmet need where new mechanisms have historically been difficult to validate.
Nemaura Medical, Inc (OTC:NMRD) once traded on the Nasdaq as a promising developer of needle-free glucose monitoring, but today its shares sit in the over-the-counter market at a fraction of a cent, effectively flat in the last closing session. For a name built around …
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has quietly built one of the more tangible commercial stories among micro-cap neurotech names, turning a specialized electrode technology into cleared, revenue-generating products. A slight pullback in the shares is what flagged the ticker, but the durable narrative …
Motus GI Holdings (OTC:MOTS) drew notice at the close for a 100% single-session gain, but the arithmetic behind that number is less dramatic than the headline figure suggests. Shares moved from $0.0001 to $0.0002, a rise of exactly one hundredth of a cent, on …